Successful development of new coronavirus vaccine in China ,Clinical trials of 2019-ncov (sars-cov-2) vaccine approved by Chen Wei team in Russia and Pakistan

Coronavirus cases around the planet have surpassed the 27 million mark and resulted in 8,87,596 deaths.


02/7There are more than 160 potential vaccines…
At a time when different countries are in a hurry to come up with coronavirus vaccine, China on Monday has put its homegrown coronavirus vaccines on screen for the first time in a Beijing trade fair this week. Additionally Read -‘Ishq’,’Mushk’ Between Congress, China is Evident, Alleges BJP Amid Border Tension


Made by Chinese companies Sinovac Biotech and Sinopharm, the vaccine is yet to hit the market but the makers of the vaccine believe it’ll be approved following all-important stage 3 trials as early as year-end. Also Read – Has Chinese Army Kidnapped 5 Men Out Of Arunachal’s Nacho Area? Team Sent to Probe The Claim


China has ramped up its efforts in the global race of developing a vaccine for COVID-19 as well as per media reports, four more nations have been awarded the go-ahead to begin the last-stage clinical trials of vaccine candidates developed by Sinovac Biotech and China National Biotec Group (CNBG).


The company in a statement told a news agency which it has completed the building of a vaccine mill which will have the ability to produce 300 million doses a year. Additionally Read ‘Action of Chinese Troops at Violation of Bilateral Agreements’,” Rajnath Singh Tells Chinese Counterpart
Not yet given any official title, the vaccine, which is on display at the Beijing Trade Fair are one of nearly 10 global vaccines to enter phase 3 trials.


Russia had last month claimed that it has developed word’s earliest corona vaccine with the name’Sputnik V’ after the Soviet-era satellite which was the first introduced into space in 1957.
As per reports, the Sputnik V,” Russia’s COVID vaccine, has passed premature trial evaluation and the patients involved in early evaluations developed antibodies with no severe adverse effects, a research article published in The Lancet stated.
Previously, Russia had said it is planning to produce 6 million doses of coronavirus vaccine each month. The RIA news agency mentioned Russian Industry Minister Denis Manturov as saying that Russia is planning to produce between 1.5 million and 2 million doses per month of its potential coronavirus vaccine by the year end.


Several coronavirus vaccine programmers in China have readied their centers for mass production, though the medication is still undergoing clinical trials and has no industry approval nonetheless. Once found and accepted, the Covid-19 vaccines will be in high demand for use in efforts to control the worldwide coronavirus pandemic. The facilities at the Chinese capital Beijing could create as many as 300 million doses per year.
The Sputnik V vaccine consists of two shots that use various variations of adenoviruses — virus kinds, a few of which cause the common cold — that the producers have engineered to carry the gene for the surface of SARS-CoV-2 which leads to COVID-19.



Leave a Reply

Your email address will not be published. Required fields are marked *